Integrating Palliative and Critical Care (IPACC) Study
- Conditions
- Any Disease Causing Death in the ICU or Within 24 Hours of Discharge From the ICU
- Interventions
- Behavioral: EducationBehavioral: Local ChampionsBehavioral: Institution FeedbackBehavioral: Academic DetailingBehavioral: Institutional Forms
- Registration Number
- NCT00685893
- Lead Sponsor
- University of Washington
- Brief Summary
The purpose of this research study is to evaluate an intervention to improve the care given to patients who are dying in the intensive care unit (ICU) and their families. This study is a multi-center randomized trial of a multi-faceted quality improvement intervention designed to improve the quality of palliative and end-of-life care in the ICU setting. The intervention targets the hospital and the outcome evaluation occurs at the level of the individual patient and family with surveys completed by family members and nurses as well as standardized medical record review.
- Detailed Description
Because of the severity of illness, the intensive care unit (ICU) is a setting where death is prevalent and where the majority of deaths involve decisions to withhold or withdraw life-sustaining therapies. There is substantial data to suggest that the quality of end-of-life care in the ICU is poor. Many patients die with moderate to severe pain, physicians are often unaware of patients' wishes regarding end-of-life care, and the care patients' receive is often not consistent with their treatment preferences. Our study aims to evaluate the effectiveness of a multi-faceted intervention to improve the quality of care for patients dying in, or shortly after a stay in, the ICU using a randomized controlled study of 12 hospitals. In addition we plan to examine the variability in, and predictors of, the quality of dying and end-of-life care in community hospital ICUs with the purpose of identifying the current quality of end-of-life care and the institutional, clinician, and patient factors associated with the quality of this care. We will evaluate the successful and unsuccessful components of the intervention and describe the institutional and clinician facilitators and barriers to the intervention's implementation, with a focus on identifying interventions to improve care for the dying at other sites.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3498
- patients, family members, nurses, and clinician evaluators
Patients are eligible if they are:
- in the ICU for a minimum of 6 hours AND,
- if they die in an ICU or within 24 hours of transfer out of the ICU.
Family members or significant others are eligible if:
- they were involved with the patient who has died.
Nurses are eligible if:
- they cared for an eligible patient on either the shift during which the patient died or the shift preceding the death.
Clinicians are eligible to evaluate the intervention components if they:
- work in a study ICU AND
- participate in any of the intervention components.
- Inability to read English well enough to complete the surveys
- Under 18 years of age.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Arm Education 6 community hospital ICUs receiving 5-component intervention. Intervention Arm Local Champions 6 community hospital ICUs receiving 5-component intervention. Intervention Arm Institution Feedback 6 community hospital ICUs receiving 5-component intervention. Intervention Arm Academic Detailing 6 community hospital ICUs receiving 5-component intervention. Intervention Arm Institutional Forms 6 community hospital ICUs receiving 5-component intervention.
- Primary Outcome Measures
Name Time Method Total Score on a survey: the Quality of Dying and Death (QODD) as assessed by family members. 5 years
- Secondary Outcome Measures
Name Time Method Total score of the QODD, as assessed by nurses 5 years Satisfaction with care, as assessed by a survey called Family Satisfaction with the ICU (FS-ICU) as assessed by family members 5 years Indicators of quality of end-of-life care as assessed by standardized medical record review. 5 years
Trial Locations
- Locations (15)
Overlake Hospital Medical Center
🇺🇸Bellevue, Washington, United States
Evergreen Hospital Medical Center
🇺🇸Kirkland, Washington, United States
Stevens Hospital
🇺🇸Edmonds, Washington, United States
Highline Medical Center
🇺🇸Burien, Washington, United States
Harrison Memorial Hospital
🇺🇸Bremerton, Washington, United States
Valley Medical Center
🇺🇸Renton, Washington, United States
Swedish Medical Center; Ballard Campus
🇺🇸Seattle, Washington, United States
Veteran's Affairs Puget Sound HCS
🇺🇸Seattle, Washington, United States
Virginia Mason Medical Center
🇺🇸Seattle, Washington, United States
University of Washington; Harborview Medical Center
🇺🇸Seattle, Washington, United States
Swedish Medical Center; Cherry Hill Campus
🇺🇸Seattle, Washington, United States
Northwest Hospital Medical Center
🇺🇸Seattle, Washington, United States
Swedish Medical Center; First Hill Campus
🇺🇸Seattle, Washington, United States
Saint Joseph Hospital
🇺🇸Tacoma, Washington, United States
University of Washington; UW Medical Center
🇺🇸Seattle, Washington, United States